[fcb5af]: / literature / by_gene / TCL1A.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 35835912 10.1038/s41588-022-01121-z 2022 Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. TCL1A
2 32247279 10.1016/j.biopha.2020.110107 2021 Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene. TCL1A
3 34206047 10.3390/cells10061367 2021 TCL1A, B Cell Regulation and Tolerance in Renal Transplantation. TCL1A
4 34771618 10.3390/cancers13215455 2021 The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A. TCL1A
5 30151355 10.3389/fonc.2018.00317 2020 T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways. TCL1A
6 31238062 10.1016/j.ejphar.2019.172494 2020 Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy. TCL1A
7 31564197 10.1080/15384101.2019.1672465 2020 The TCL1 function revisited focusing on metabolic requirements of stemness. TCL1A
8 31932115 10.1016/j.prp.2019.152799 2020 TCL1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods. TCL1A
9 29048125 10.1111/bjh.14989 2019 TCL1A interacts with TP63 and enhances the survival of Raji Burkitt lymphoma cell line. TCL1A
10 29375549 10.3389/fimmu.2017.01841 2019 Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome. TCL1A
11 30282833 10.1172/jci.insight.121438 2019 Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies. TCL1A
12 30286151 10.1371/journal.pone.0204775 2019 T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1. TCL1A
13 30865410 2019 Blastic plasmacytoid dendritic cell neoplasm: an early presentation. TCL1A
14 27229929 10.1186/s12885-016-2374-2 2017 Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor. TCL1A
15 27284738 10.1038/bcj.2016.41 2017 p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL. TCL1A
16 28178623 10.1016/j.biopha.2017.01.128 2017 T-cell leukemia/lymphoma-1A predicts the clinical outcome for patients with stage II/III colorectal cancer. TCL1A
17 25688912 10.1111/ejh.12539 2016 TCL1 expression predicts overall survival in patients with mantle cell lymphoma. TCL1A
18 25936528 10.1038/leu.2015.114 2016 The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL. TCL1A
19 26308769 10.1038/leu.2015.237 2016 Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. TCL1A
20 26866883 10.1210/me.2015-1267 2016 Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation. TCL1A
21 26917488 10.1111/bjh.13952 2016 Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia. TCL1A
22 24634383 10.1158/1078-0432.CCR-13-1597 2015 EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations. TCL1A
23 24966976 2015 T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15;q32) [TCRγ-TCL1A translocation]: a case report and a review of the literature. TCL1A
24 25564405 10.1182/blood-2014-07-587790 2015 Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL. TCL1A
25 25576290 10.1016/j.humpath.2014.11.009 2015 Primary mediastinal seminomas: a comprehensive immunohistochemical study with a focus on novel markers. TCL1A
26 25646413 10.1073/pnas.1500010112 2015 TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia. TCL1A
27 24461094 10.1016/j.annder.2013.10.042 2014 [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face]. TCL1A
28 24713242 2014 [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases]. TCL1A
29 22553924 10.3109/10428194.2012.690098 2013 Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes. TCL1A
30 22674796 10.1002/cyto.a.22072 2013 Intracytoplasmic detection of TCL1--but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis. TCL1A
31 22808135 10.1371/journal.pone.0040332 2013 Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma. TCL1A
32 23064660 10.1007/s00428-012-1322-z 2013 Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. TCL1A
33 23160471 10.1182/blood-2012-09-457374 2013 Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas. TCL1A
34 23630447 10.7150/ijbs.6058 2013 Genomic profiling reveals the potential role of TCL1A and MDR1 deficiency in chemotherapy-induced cardiotoxicity. TCL1A
35 21960592 10.1182/blood-2011-06-361972 2012 MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. TCL1A
36 22065599 10.1182/blood-2011-08-374561 2012 Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies. TCL1A
37 22308499 10.1073/pnas.1200003109 2012 Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL). TCL1A
38 22645177 10.1182/blood-2011-09-382838 2012 TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas. TCL1A
39 22918421 10.1182/blood-2012-07-435123 2012 Toward an off-the-shelf vaccine for B-cell malignancies. TCL1A
40 20079013 2011 [Immunohistochemical study using T-cell lymphoma antibody 1 and CD44 in diagnosis of Burkitt's lymphoma]. TCL1A
41 20504151 10.1089/scd.2009.0424 2011 Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A. TCL1A
42 20802470 10.1038/modpathol.2010.139 2011 E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response. TCL1A
43 19668332 10.1371/journal.pone.0006567 2010 The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB. TCL1A
44 19889012 10.1111/j.1600-0609.2009.01369.x 2010 IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia. TCL1A
45 19966860 10.1038/onc.2009.439 2010 Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b. TCL1A
46 20357824 10.1038/leu.2010.46 2010 CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation. TCL1A
47 20382409 10.1016/j.humpath.2010.01.015 2010 T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma. TCL1A
48 20687795 10.3109/10428194.2010.505064 2010 Pharmacologic interception in T-cell leukemia 1A associated pathways as a treatment rationale for chronic lymphocytic leukemia. TCL1A
49 20864035 10.1016/j.molcel.2010.08.019 2010 AID-induced genotoxic stress promotes B cell differentiation in the germinal center via ATM and LKB1 signaling. TCL1A
50 18820675 10.1038/modpathol.2008.148 2009 TCL1A expression delineates biological and clinical variability in B-cell lymphoma. TCL1A
51 19064921 10.1073/pnas.0810965105 2009 Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. TCL1A
52 19155496 10.4049/jimmunol.182.3.1490 2009 T cell leukemia/lymphoma 1 and galectin-1 regulate survival/cell death pathways in human naive and IgM+ memory B cells through altering balances in Bcl-2 family proteins. TCL1A
53 19388928 10.1111/j.1365-2141.2009.07679.x 2009 Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. TCL1A
54 19816150 10.1097/PAS.0b013e3181bb9a18 2009 Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome. TCL1A
55 18162778 10.1097/PAS.0b013e3180959e09 2008 Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation. TCL1A
56 18184868 10.1182/blood-2007-10-119099 2008 Pathway analysis of primary central nervous system lymphoma. TCL1A
57 18628085 10.1309/PNXUKA1CFJMVGCN1 2008 Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization. TCL1A
58 17151114 10.1128/JVI.01822-06 2007 EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells. TCL1A
59 17548807 10.1073/pnas.0704170104 2007 TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation. TCL1A
60 17592280 10.1097/PAS.0b013e31802e2201 2007 TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage. TCL1A
61 17625607 10.1038/sj.leu.2404853 2007 MicroRNA losses in the frequently deleted region of 7q in SMZL. TCL1A
62 16354329 10.3816/CLM.2005.n.051 2006 T-cell prolymphocytic leukemia: a single-institution experience. TCL1A
63 16610948 10.2217/14622416.7.3.375 2006 Gene expression profile of empirically delineated classes of unexplained chronic fatigue. TCL1A
64 16978196 10.1111/j.1365-2559.2006.02506.x 2006 Expression of TCL1 and CD27 in primary cutaneous B-cell lymphomas. TCL1A
65 15586235 2005 Identification of TCL1A as an immunohistochemical marker of adverse outcome in diffuse large B-cell lymphomas. TCL1A
66 16056259 10.1038/nrc1672 2005 The TCL1 family of oncoproteins: co-activators of transformation. TCL1A
67 16146820 10.1309/77V7U4E03V69QHRR 2005 TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma. TCL1A
68 12576313 10.1182/blood-2002-10-3297 2004 TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. TCL1A
69 12962701 10.1016/s1357-2725(03)00146-8 2004 TCL1: a new drug target in lymphoid and germ-cell malignancies? TCL1A
70 12969959 10.1182/blood-2003-05-1710 2004 Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression. TCL1A
71 14607063 10.1016/j.tim.2003.09.009 2004 Epstein-Barr virus, the TCL-1 oncogene and Burkitt's lymphoma. TCL1A
72 15323148 10.1309/0QPP-AVTU-PCV9-UCLV 2004 TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. TCL1A
73 15325703 10.1016/j.hoc.2004.04.007 2004 Tcl1 as a model for lymphomagenesis. TCL1A
74 12615201 10.1016/s1471-4906(03)00022-x 2003 Akt is TCL-ish: implications for B-cell lymphoma. TCL1A
75 12672960 10.1073/pnas.0730710100 2003 T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines. TCL1A
76 11707444 10.1074/jbc.M107069200 2002 Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. TCL1A
77 11752899 10.1159/000048758 2002 Expression of TCL1 in hematologic disorders. TCL1A
78 11802372 2002 [Searching for the disease related genes from human chromosome 14]. TCL1A
79 11857346 10.1002/ijc.10102 2002 TCL-1, MTCP-1 and TML-1 gene expression profile in non-leukemic clonal proliferations associated with ataxia-telangiectasia. TCL1A
80 12127395 10.1016/s0165-4608(01)00655-0 2002 Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression. TCL1A
81 12381789 10.1073/pnas.212410199 2002 Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. TCL1A
82 11241786 10.1002/gcc.1099 2001 TCL1 is activated by chromosomal rearrangement or by hypomethylation. TCL1A
83 11304575 10.1038/labinvest.3780264 2001 TCL1 oncogene expression in B cell subsets from lymphoid hyperplasia and distinct classes of B cell lymphoma. TCL1A
84 11342319 10.3109/10428190009065838 2001 Consistent loss of heterozygosity at 14Q32 in lymphoid blast crisis of chronic myeloid leukemia. TCL1A
85 11607815 10.1038/sj.onc.1204596 2001 The role of TCL1 in human T-cell leukemia. TCL1A
86 11710897 10.1001/jama.286.18.2308 2001 Molecular basis of mature T-cell leukemia. TCL1A
87 10716693 10.1073/pnas.97.7.3028 2000 Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. TCL1A
88 10786666 2000 Regulation of TCL1 expression in B- and T-cell lymphomas and reactive lymphoid tissues. TCL1A
89 10792782 10.1046/j.1440-1827.2000.01023.x 2000 Activation of the TCL1 protein in B cell lymphomas. TCL1A
90 10851082 10.1038/sj.onc.1203604 2000 Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. TCL1A
91 10449776 10.1073/pnas.96.17.9809 1999 TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues. TCL1A
92 9639427 10.1038/sj.leu.2401023 1998 Amplification of the TCL1 flanking region at 14q32.1 with no TCL1 gene transcription in a patient with peripheral T cell lymphoma. TCL1A
93 9738977 10.1111/j.1349-7006.1998.tb03275.x 1998 Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia. TCL1A
94 8570215 1996 Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients. TCL1A
95 7987816 1995 Characterization and localization of the TCL-1 oncogene product. TCL1A